Filing Flows

Filing Flows › Rani Therapeutics Holdings (RANI) › Next earnings date

Rani Therapeutics Holdings (RANI) earnings on Nov 10, 2026: what to expect

Rani Therapeutics Holdings (RANI) is expected to report earnings on Nov 10, 2026 (estimated), in 2 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.05 (−$0.05 to −$0.04, 3 estimates) on revenue of $1.3M, against −$0.12 a year ago. It beat the EPS estimate in 75% of the quarters on record; Filing Flows' model gives it a 77% chance of beating next time.

Report dateNov 10, 2026 (estimated)
Days to go2
EPS estimate−$0.05
Revenue estimate$1.3M
Beat rate75%

The last report

Rani Therapeutics Holdings reported revenue of $1.7M for the second quarter 2026, net loss $8.4M. How it makes money → · Every quarter →

Rani Therapeutics Holdings: EPS against the estimate, last 4 reportsRani Therapeutics Holdings: EPS against the estimate, last 4 reportsEstimateReported−$0.12−$0.12Nov 25−$0.07−$0.07Mar 26−$0.04−$0.04May 26−$0.05−$0.04Aug 26
Latest (Aug 26): Estimate −$0.05, Reported −$0.04.

Rani Therapeutics Holdings' latest quarter

Rani Therapeutics Holdings, Q2 2026: revenue $1.7M, operating margin -516.9%, net loss $8.4M, operating cash flow −$9.0M. The chart follows the revenue to costs, profit and cash.

Questions

When does RANI report earnings?

Rani Therapeutics Holdings is expected to report on Nov 10, 2026 (estimated).

What are analysts expecting from Rani Therapeutics Holdings?

EPS of −$0.05 and revenue of $1.3M for the quarter.

Does Rani Therapeutics Holdings usually beat earnings?

It beat the consensus EPS estimate in 75% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.